1. Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes Am J Respir Crit Care Med.2013;187(2):197-205. Marinka Kartalija, Alida R. Ovrutsky, Courtney L. Bryan, Gregory B. Pott, Giamila Fantuzzi, Jacob Thomas, Matthew J. Strand, Xiyuan Bai, Preveen Ramamoorthy, Micol S. Rothman, Vijaya Nagabhushanam, Michael McDermott, Adrah R. Levin, Ashley Frazer-Abel, Patricia C. Giclas, Judith Korner, Michael D. Iseman, Leland Shapiro, and Edward D. Chan 호흡기 내과 / R4 이민혜

2. Introduction Chronic lung disease due to nontuberculous mycobacteria (NTM) –Although NTM are widespread in water and soil, relatively few persons develop disease  Intact immunity is likely pivotal for protection against NTM –The incidence in the US Five to six cases per 100,000 Over 50 years of age : as high as 15.5 cases per 100,000 –The prevalence of disease Estimated to be 10 to 40 cases per 100,000 – The most common NTM species associated with lung disease(US) Mycobacterium avium complex (MAC) Mycobacterium kansasii Mycobacterium abscessus –2 main radiographic patterns Upper lobe fibrocavitary pattern that occurs mostly in men with underlying lung disease such as COPD Nodular-bronchiectasis pattern that often involves the right middle lobe and lingula and which appears to be more common in women with no clear risk factors

3. Introduction Predisposing factor of mycobacterial infections –Slender body habitus –Low body mass index(BMI) –Hong Kong study showing that obesity was associated with a lower risk of TB Hypothesis of this study –Slender individuals: abnormal expression of leptin and adiponectin, adipokines (important immune modulators) –Adiposity: leptin↑/adiponectin↓ –Relative deficiency of leptin: reduced lymphopoiesis and impaired differentiation of T cells into the IFN-γ–producing T H 1 phenotype –Leptin Activates macrophages Increases production of host-protective cytokines (ex. TNF-α, IL-12) –Reduced leptin levels in slender individuals  increased susceptibility to TB –Adiponectin Induce immunosuppressive cytokines (ex. IL-10, IL-1 receptor antagonist) Elevated levels in slender individuals may impair their resistance to NTM

4. Introduction Predisposing factor of mycobacterial infections –Slender body habitus –Low body mass index(BMI) –Hong Kong study showing that obesity was associated with a lower risk of TB

5. Introduction Predisposing factor of mycobacterial infections –Slender body habitus –Low body mass index(BMI) –Hong Kong study showing that obesity was associated with a lower risk of TB Hypothesis of this study –Slender individuals: abnormal expression of leptin and adiponectin, adipokines (important immune modulators) –Adiposity: leptin↑/adiponectin↓ –Relative deficiency of leptin: reduced lymphopoiesis and impaired differentiation of T cells into the IFN-γ–producing T H 1 phenotype –Leptin Activates macrophages Increases production of host-protective cytokines (ex. TNF-α, IL-12) –Reduced leptin levels in slender individuals  increased susceptibility to TB –Adiponectin Induce immunosuppressive cytokines (ex. IL-10, IL-1 receptor antagonist) Elevated levels in slender individuals may impair their resistance to NTM

6. Methods Prospective, cross-sectional study Between 2009.12.01~2010.10.01 103 patients with pNTM (Adult Day Unit of National Jewish Health (NJH)) 101 control subjects (the University of Colorado Denver Anschutz Medical Campus Metabolic Bone Clinic) Body morphotype measurements Assessment for scoliosis and PEX(pectus excavatum) Adipokine measurements Whole-Blood cytokine levels

7. Results There was no significant difference in age, gender, or race between the patients with pNTM and control subjects More patients with pNTM were current or past smokers, but in both groups the vast majority with tobacco use were former smokers

8. Results Although there was a trend toward greater prevalence of COPD in the pNTM cohort, this was self- reported and may reflect airway dysfunction related to bronchiectasis and not classic COPD The pNTM cohort was also more likely to have a history of childhood respiratory disease, sinusitis, and gastroesophageal reflux Osteoporosis and osteopenia were more common among control subjects, although the prevalence was high in both groups

9. Results <>><<>><

10. P<0.0001 P=0.02

11. Results 53 control subjects (open bars) 47 patients with pNTM (closed bars) 53 control subjects (open bars) 47 patients with pNTM (closed bars) *P < 0.05 **P < 0.01 ****P < 0.0001

12. Results

13. IL-10: antiinflammatory cytokine Low IFN-γ/IL-10 ratio  associated with disease severity in TB

14. Discussion This study is the first to examine body morphotype, adipokines, and blood cytokine levels in patients with pNTM and control subjects with similar demographics in regard to age, gender, and race Patients with pNTM have lower BMI and less body fat supports the hypothesis that thin individuals are more susceptible to NTM lung disease Patients with pNTM have an increased frequency of the anthropometric features (taller stature, thin body habitus, scoliosis, and PEX) seen in Marfan syndrome

15. Discussion In patients with pNTM, the typical direct relationship between body fat and serum leptin level was essentially absent Elevated serum adiponectin in the pNTM cohort because adiponectin increases as body fat decreases IFN-γ and IL-10 levels were reduced in patients with pNTM, an imbalance between immune-activating IFN-γ and immunosuppressive IL-10 may predispose slender individuals with abnormal body habitus to pNTM infection

16. Conclusion Compared with a control group with similar demographics, patients and pNTM were taller and thinner, and had more thoracic cage abnormalities Serum leptin and adiponectin levels were abnormally regulated in the patients with pNTM After whole-blood stimulation, IFN-γ and IL-10 levels were significantly suppressed in the patients with pNTM Future studies to explore a possible genetic basis for the abnormal immunophenotype and to clarify the molecular mechanisms responsible for the abnormal induction of leptin, adiponectin, IFN-γ, and IL-10 in patients with NTM lung disease